Sunday, June 3, 2012

LINKS TO ASCO MEETING NEWS

Hope for Aggressive HER2+ Mets:
http://www.nytimes.com/2012/06/03/health/research/in-study-drug-delays-worsening-of-breast-cancer-with-fewer-side-effects.html?_r=2&adxnnl=1&hpw=&adxnnlx=1338725291-cxRpDYDBLxAdlge6AzseSQ


No comments: